Organigram Global (OGI) Other Non-Current Assets (2018 - 2025)
Organigram Global (OGI) reported Other Non-Current Assets of $36.0 million for Q3 2025, up 20.59% year-over-year from $29.9 million in Q3 2024, and up 20.59% quarter-over-quarter from $29.9 million in Q3 2024.
Organigram Global (OGI) Other Non-Current Assets (2018 - 2025) Analysis & Trends
Organigram Global (OGI) has 7 years of Other Non-Current Assets data on file, last reported at $36.0 million in Q3 2025.
- Other Non-Current Assets for Q3 2025 came in at $36.0 million, up 20.59% year-over-year; the trailing twelve-month figure through Sep 2025 was $36.0 million (up 20.59% YoY), and the FY2025 annual result was $36.0 million, up 20.24% from the prior year.
- Other Non-Current Assets improved to $36.0 million in Q3 2025 per OGI's latest filing, from $29.9 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $36.0 million in Q3 2025 and troughed at $687000.0 in Q4 2021.
- A 5-year average of $22.4 million and a median of $25.0 million in 2021 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2021 and 2022: Other Non-Current Assets jumped 318.69% in 2021, then dropped 16.78% in 2022.
- A 5-year view of Other Non-Current Assets shows it stood at $687000.0 in 2021, then soared by 2931.47% to $20.8 million in 2022, then tumbled by 35.91% to $13.3 million in 2023, then soared by 123.68% to $29.9 million in 2024, then grew by 20.59% to $36.0 million in 2025.
- Business Quant data shows OGI's Other Non-Current Assets at $36.0 million in Q3 2025, $29.9 million in Q3 2024, and $13.3 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Organigram Global | 731.20 Mn | 673.26 Mn | 11.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 36.00 Mn |
| Sep 30, 2024 | 29.86 Mn |
| Sep 30, 2023 | 13.35 Mn |
| Aug 31, 2022 | 20.83 Mn |
| Nov 30, 2021 | 687,000.00 |
| Aug 31, 2021 | 25.03 Mn |
| May 31, 2021 | 31.11 Mn |
| Aug 31, 2020 | 5.98 Mn |
| Aug 31, 2018 | 1.22 Mn |